EUCTR2012-005066-36-NL进行中（未招募）不适用
Effect of Growth Hormone replacement therapy on cardiovascular risk factors in adult patients with severe growth hormone deficiency: association with IGF-I concentration - GH and cardiovascular risk factors
VU University Medical Center0 个研究点开始时间: 2013年1月23日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Ongoing surveillance at our centre (VUmc, Amsterdam)
- •- GH treated (at least one year)
- •- Men and women with an age between 20 and 65 years, both childhood as adult onset GHD
- •- Stable substitution therapies for other pituitary hormone deficiencies
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 32
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Subjects with a craniopharyngioma as cause of their GHD or pituitary deficiencies
- •- Contraindications for the use of Growth Hormone treatment
- •- (Receiving treatment for) malignant disease (in the past)
- •- Cardiovascular event less than one year prior to inclusion
- •- Participation in other studies
- •- Subjects, who in the opinion of the investigator, are unsuitable in any other way to participate in this study
研究者
相似试验
已完成
不适用
Effect of Growth Hormone replacement therapy on cardiovascular risk factors in adult patients with severe growth hormone deficiency: association with IGF-I concentratiogrowth hormone deficiency10021112NL-OMON39563Vrije Universiteit Medisch Centrum32
尚未招募
不适用
Effects of growth hormone (GH) replacement therapy in GH deficient adult childhood cancer survivors on organ size and microvascularisation of kidney and skin.growth hormone deficiency1002111210038430NL-OMON33094ovo Nordisk50
进行中（未招募）
不适用
Effects of growth hormone treatment to patients with partial growth hormone deficiency, with special emphasis on acute phase proteins and pro-inflammatory cytokines.EUCTR2005-004478-26-SEKarolinska universitetssjukhuset
已完成
不适用
Growth hormone deficiency and clottingISRCTN59234325eeds Teaching Hospitals NHS Trust (UK)140
已完成
不适用
Growth Hormone (GH) Replacement Therapy Decreased Plasma Diacron-reactive Oxygen Metabolites levels and subsequently, improved Endothelial Function as Assessed by Peripheral Arterial Tonometry in Japanese Patient with growth Hormone deficiencyGrowth Hormone DeficiencyJPRN-UMIN000025223Dokkyo Medical University15